Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE SAINTE- ANNE : revenue, balance sheet and financial ratios

SELARL PHARMACIE SAINTE- ANNE is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in REIMS (51100), this company of category PME shows in 2019 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE SAINTE- ANNE (SIREN 518012844)
Indicator 2025 2019
Revenue N/C 1 143 285 €
Net income 29 755 € 20 763 €
EBITDA N/C 68 456 €
Net margin N/C 1.8%

Revenue and income statement

In 2025, SELARL PHARMACIE SAINTE- ANNE generates positive net income of 30 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 21 k€ -> 30 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

29 755 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 57%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

56.783%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

49.864%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

3.0%

Solvency indicators evolution
SELARL PHARMACIE SAINTE- ANNE

Sector positioning

Debt ratio
56.78 2025
2019
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average -9 pts over 2 years

In 2025, the debt ratio of SELARL PHARMACIE SAINTE- ... (56.78) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
49.86% 2025
2019
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average +8 pts over 2 years

In 2025, the financial autonomy of SELARL PHARMACIE SAINTE- ... (49.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
16.43 years 2019
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.49 years
Watch

In 2019, the repayment capacity of SELARL PHARMACIE SAINTE- ... (16.43) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 55.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

55.319

Liquidity indicators evolution
SELARL PHARMACIE SAINTE- ANNE

Sector positioning

Liquidity ratio
55.32 2025
2019
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch

In 2025, the liquidity ratio of SELARL PHARMACIE SAINTE- ... (55.32) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
36.52x 2019
2019
Q1: 1.36x
Med: 5.4x
Q3: 11.35x
Excellent

In 2019, the interest coverage of SELARL PHARMACIE SAINTE- ... (36.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE SAINTE- ANNE

Positioning of SELARL PHARMACIE SAINTE- ANNE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE SAINTE- ANNE is estimated at 472 661 € (range 320 750€ - 741 671€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
320k€ 472k€ 741k€
472 661 € Range: 320 750€ - 741 671€
NAF 5 année 2025

Valuation method used

Net Income Multiple
29 755 € × 15.9x = 472 662 €
Range: 320 750€ - 741 671€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE SAINTE- ANNE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE SAINTE- ANNE

What is the revenue of SELARL PHARMACIE SAINTE- ANNE ?

The revenue of SELARL PHARMACIE SAINTE- ANNE in 2019 is 1.1 M€.

Is SELARL PHARMACIE SAINTE- ANNE profitable?

Yes, SELARL PHARMACIE SAINTE- ANNE generated a net profit of 30 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE SAINTE- ANNE ?

The headquarters of SELARL PHARMACIE SAINTE- ANNE is located in REIMS (51100), in the department Marne.

Where to find the tax return of SELARL PHARMACIE SAINTE- ANNE ?

The tax return of SELARL PHARMACIE SAINTE- ANNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE SAINTE- ANNE operate?

SELARL PHARMACIE SAINTE- ANNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.